Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Let's Invest: Are you prepared for do-it-yourself investing?

In our fourth segment of our “Let’s Invest” series’ with Jean-Paul Bureaud, executive director of FAIR Canada , we stay on the self-investing side with DIY – do-it-yourself investing. Bureaud goes over the pros and co...
Coreena Robertson | June 11, 2024 |

Lithium and copper demand set to grow in 2025

Lithium has already seen a rise in price since the U.S. presidential election and analysts predict a huge demand for copper . Grid Battery Metals (TSXV:CELL) has lithium projects in Nevada and a Copper in British Columbia and the company’s CEO, Tim Fer...
Research | December 6, 2024 |

Lower inflation primes Canada's real estate market for a shift

June’s inflation rate reduced to 2.7 percent from 2.9 percent in May, giving the BOC a reason to lower the current policy interest rate. On June 5 the Bank of Canada lowered the interest rate 25 basis points to 4.75 per cent, and experts are betting on ano...
Coreena Robertson | July 24, 2024 |

BioNTech, EXMceuticals, XPhyto - Covid-19 and legalizations offer potential

In recent months, the society around the globe has been going through a process of change of deceleration and standstill. Priorities have been redefined and implemented at record speeds in many places. Covid-19 serves as a catalyst for change for many people. The reasons can b...
Mario Hose | July 15, 2020 |

'Data Readouts Approaching in Two Pivotal Trials' for Biopharma Targeting Unmet Needs

The next steps for each of the programs are outlined in a Dawson James Securities report. In an Aug. 14 research note, Dawson James Securities analyst Jason Kolbert reported that Soligenix Inc. (SNGX:NASDAQ) "is now focused on the two pivotal programs, i...
Streetwise Reports | August 22, 2019 |

U.S. Biotech Rolls Out New Brachytherapy Delivery Tool Used for Prostate Cancer

The system, target markets and the marketing campaign for it are discussed in a Dawson James Securities report. In a Sept. 26 research note, Dawson James Securities analyst Jason Kolbert reported that IsoRay Inc. (ISR:NYSE.MKT) launched a new marketing campaign call...
Streetwise Reports | October 1, 2019 |

Soliton Shares Rise on Announcement It Will Report Clinical Data at National Dermatology Conference

Soliton Inc. shares traded 10% higher today after advising that later this month it will present the data from clinical trials for its Rapid Acoustic Pulse device used in the treatment of keloid and hypertrophic scars at the American Society for Dermatologic Surgery Annual Mee...
Streetwise Reports | October 10, 2019 |

Will Central Banks Prevent Recession and Push Gold Down?

Will Central Banks Prevent Recession and Push Gold Down? Trade wars, geopolitical tensions and slowing economic indicators. Both the ECB and the Fed have recently cut interest rates to stimulate slowing growth, hoping to escape possible recession. Will they succeed? A...
Arkadiusz Sieron | October 28, 2019 |

Analyst Believes Biopharma's Alzheimer's Treatment Could Be Superior to Biogen's

How this company's Alzheimer's therapeutic compares to an advanced-stage competitor is outlined in a Dawson James Securities note. In a Dec. 2 research note, Dawson James Securities analyst Jason Kolbert purported that Anavex Life Sciences Corp.'s (AVXL:NASDAQ) ANAV...
Streetwise Reports | December 11, 2019 |

Biotech Announces Deal with Bayer on Non-Hormonal Contraception

Details of the arrangement and an update on the company's pipeline are provided in a Dawson James report. In a Jan. 13 research note, Dawson James Securities analyst Jason Kolbert reported that Daré Bioscience Inc. (DARE:NASDAQ) partnered with Bayer, the company beh...
Streetwise Reports | January 16, 2020 |
1 2 3 4 5 6 7 8 9 10 ...